OPEC Meeting Caught between Internal Approval of Extension and Russian Stalling

The logo of the Organization of the Petroleum Exporting Countries (OPEC) is pictured at its headquarters in Vienna, Austria September 21, 2017.
The logo of the Organization of the Petroleum Exporting Countries (OPEC) is pictured at its headquarters in Vienna, Austria September 21, 2017.
TT

OPEC Meeting Caught between Internal Approval of Extension and Russian Stalling

The logo of the Organization of the Petroleum Exporting Countries (OPEC) is pictured at its headquarters in Vienna, Austria September 21, 2017.
The logo of the Organization of the Petroleum Exporting Countries (OPEC) is pictured at its headquarters in Vienna, Austria September 21, 2017.

Despite talks about extending the oil cut deal up to six months, many sources affirmed that Thursday’s OPEC meeting will not carry any surprises since members agree to extend the agreement for nine months (until the end of 2018).

Russia, however, continues to stall in deciding the extension duration, even though President Vladimir Putin approved the extension until the end of 2018 – but some firms objected and requested a shorter period.

Moscow stated on Friday that it is ready to back the extension of the oil curb deal, but it has not yet decided on the duration.

Oil Ministers started to arrive in Vienna on Tuesday where OPEC is based.

Thursday’s gathering appears to be a historic and decisive meeting, with around 300 journalists covering the event.

The deal is aimed at curbing crude oil reserves in industrial countries to its average in five years. Sources told Asharq Al-Awsat that the purpose might be achieved by the third quarter of 2018.

Saudi Energy Minister Khalid al-Falih said Tuesday that it was too early to talk about the duration, while UAE Minister for Energy Suhail al-Mazroui stated that the meeting will not be easy.

“We believe that the outcome of this meeting is much more uncertain than usual,” Goldman wrote.

“The absence of such a consensus is due to the uncertainty on the progress of the oil market re-balancing as well as Brent oil prices trading at $63 per barrel,” the bank said in a research note.

Goldman added: “The push for a nine month extension, four months before the cuts end and given an accelerating re-balancing further stands in the face of prior comments that the cuts should remain data dependent to assess their effectiveness.”



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.